Literature DB >> 31814885

MiR-145: a potential biomarker of cancer migration and invasion.

Wen-Xiu Xu1,2, Zhen Liu1,2, Fei Deng1,2, Dan-Dan Wang1, Xing-Wang Li3, Tian Tian3, Jian Zhang1, Jin-Hai Tang1,2.   

Abstract

MircoRNAs (miRNAs) are a diverse family of highly-conserved small non-coding RNAs, which range from approximately 18 to 25 nucleotides in size. They regulate gene expression transcriptionally or post-transcriptionally via binding to the 3'-untranslated region (3'-UTR) of target message RNAs (mRNAs). MiRNAs have emerged as molecular regulators that participate in physiological and pathological processes of diverse malignancies. Among them, miRNA-145 (miR-145) played a profound role in tumorigenesis and progression of various neoplasms. In this review, we summarized the recent findings regarding miR-145, to elucidate its functional roles in cell invasion and migration of diverse human malignancies, and considered it a potential biomarker for cancer diagnosis, screening, and prognosis. AJTR
Copyright © 2019.

Entities:  

Keywords:  MiR-145; biomarker; cancers; invasion and migration

Year:  2019        PMID: 31814885      PMCID: PMC6895535     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  137 in total

1.  A B-cell-specific DNA recombination complex.

Authors:  T Borggrefe; M Wabl; A T Akhmedov; R Jessberger
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

2.  lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6.

Authors:  Gabriel Eades; Benjamin Wolfson; Yongshu Zhang; Qinglin Li; Yuan Yao; Qun Zhou
Journal:  Mol Cancer Res       Date:  2014-09-24       Impact factor: 5.852

3.  miR-145 suppresses breast cancer cell migration by targeting FSCN-1 and inhibiting epithelial-mesenchymal transition.

Authors:  Hong Zhao; Xing Kang; Xuefeng Xia; Like Wo; Xidong Gu; Yuanyuan Hu; Xiaohong Xie; Helena Chang; Lihua Lou; Xuning Shen
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

4.  microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.

Authors:  Anusha Sathyanarayanan; Karthik Subramanian Chandrasekaran; Devarajan Karunagaran
Journal:  Cell Oncol (Dordr)       Date:  2016-12-08       Impact factor: 6.730

5.  Long non-coding RNA SOX21-AS1 sponges miR-145 to promote the tumorigenesis of colorectal cancer by targeting MYO6.

Authors:  An-Wei Wei; Li-Fang Li
Journal:  Biomed Pharmacother       Date:  2017-12-06       Impact factor: 6.529

Review 6.  CCN proteins: multifunctional signalling regulators.

Authors:  Bernard Perbal
Journal:  Lancet       Date:  2004-01-03       Impact factor: 79.321

7.  MicroRNA-145 functions as a tumor suppressor by targeting matrix metalloproteinase 11 and Rab GTPase family 27a in triple-negative breast cancer.

Authors:  L Tang; D Wei; F Yan
Journal:  Cancer Gene Ther       Date:  2016-07-01       Impact factor: 5.987

8.  Role of ADAM17 in the ectodomain shedding of TNF-alpha and its receptors by neutrophils and macrophages.

Authors:  Jessica H Bell; Amy H Herrera; Ying Li; Bruce Walcheck
Journal:  J Leukoc Biol       Date:  2007-05-17       Impact factor: 4.962

9.  MiR-145 suppressed human retinoblastoma cell proliferation and invasion by targeting ADAM19.

Authors:  Zhe Sun; Ai Zhang; Tao Jiang; Zhaodong Du; Chengye Che; Fang Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

10.  Long noncoding RNA UCA1 promotes the proliferation, invasion, and migration of nasopharyngeal carcinoma cells via modulation of miR-145.

Authors:  Jing Wu; Mingyu Du; Qian Zhang; Wenjun Zhang; Yanxin Fan; Li Yin; Qian Fei; Xuesong Jiang; Wei Chen; Huanfeng Zhu; Pengwei Yan; Xia He; Xiuhua Bian
Journal:  Onco Targets Ther       Date:  2018-10-25       Impact factor: 4.147

View more
  22 in total

1.  The potential value of microRNA-145 for predicting prognosis in patients with ovarian cancer: A protocol for systematic review and meta-analysis.

Authors:  Zhen Chen; Zelan Xiao; Siheng Zeng; Zhiqiang Yan
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

2.  Identification of key microRNAs as predictive biomarkers of Nilotinib response in chronic myeloid leukemia: a sub-analysis of the ENESTxtnd clinical trial.

Authors:  Ryan Yen; Sarah Grasedieck; Andrew Wu; Hanyang Lin; Jiechuang Su; Katharina Rothe; Helen Nakamoto; Donna L Forrest; Connie J Eaves; Xiaoyan Jiang
Journal:  Leukemia       Date:  2022-08-23       Impact factor: 12.883

Review 3.  Senescence-Associated miRNAs and Their Role in Pancreatic Cancer.

Authors:  Alexey Popov; Vaclav Mandys
Journal:  Pathol Oncol Res       Date:  2022-04-29       Impact factor: 2.874

4.  miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast.

Authors:  Ji Won Woo; Hye Yeon Choi; Milim Kim; Yul Ri Chung; So Yeon Park
Journal:  Breast Cancer       Date:  2022-04-22       Impact factor: 3.307

5.  Omega-3 polyunsaturated fatty acids: a modified approach for chemo-prevention of bladder cancer in a rat model and molecular studies of antineoplastic mechanisms.

Authors:  Mohamed Fadallah; Mohamed H Zahran; Ahmed M El-Assmy; Nashwa M Barakat; Sherry Khater; Amira Awadalla; Asmaa E Ahmed; E L Housseiny I Ibrahiem; Ahmed A Shokeir
Journal:  Mol Biol Rep       Date:  2022-04-25       Impact factor: 2.742

6.  MiR-145 suppresses the motility of prostate cancer cells by targeting cadherin-2.

Authors:  Huixuan Zeng; Yishan Huang; Qiuling Liu; Hongjiao Liu; Tianzhu Long; Cairong Zhu; Xiaoping Wu
Journal:  Mol Cell Biochem       Date:  2021-05-27       Impact factor: 3.396

7.  RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation.

Authors:  Masumi Wada; Yusuke Goto; Takako Tanaka; Reona Okada; Shogo Moriya; Tetsuya Idichi; Masahiro Noda; Ken Sasaki; Yoshiaki Kita; Hiroshi Kurahara; Kosei Maemura; Shoji Natsugoe; Naohiko Seki
Journal:  J Hum Genet       Date:  2020-07-04       Impact factor: 3.172

8.  miR-1253, a novel tumor suppressor gene in colon cancer, is associated with poor patients prognosis.

Authors:  Daye Yang; Dewei Zhang
Journal:  Clin Exp Med       Date:  2021-04-10       Impact factor: 3.984

Review 9.  Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway.

Authors:  Mengnan Guo; Ning Li; Jianxia Zheng; Wei Wang; Yan Wu; Xu Han; Jiapei Guo; Weixi Chen; Zekun Bai; Wen Bai; Jinghua Wu
Journal:  Can J Gastroenterol Hepatol       Date:  2021-05-25

10.  DNA Methylation Influences miRNA Expression in Gonadotroph Pituitary Tumors.

Authors:  Joanna Boresowicz; Paulina Kober; Natalia Rusetska; Maria Maksymowicz; Agnieszka Paziewska; Michalina Dąbrowska; Natalia Zeber-Lubecka; Jacek Kunicki; Wiesław Bonicki; Jerzy Ostrowski; Janusz A Siedlecki; Mateusz Bujko
Journal:  Life (Basel)       Date:  2020-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.